Aichler, M., Motschmann, M., Jütting, U., Luber, B., Becker, K., Ott, K., . . . Walch, A. (2014). Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy. Impact Journals LLC.
Citação norma ChicagoAichler, Michaela, et al. Epidermal Growth Factor Receptor (EGFR) Is an Independent Adverse Prognostic Factor in Esophageal Adenocarcinoma Patients Treated With Cisplatin-based Neoadjuvant Chemotherapy. Impact Journals LLC, 2014.
Citação norma MLAAichler, Michaela, et al. Epidermal Growth Factor Receptor (EGFR) Is an Independent Adverse Prognostic Factor in Esophageal Adenocarcinoma Patients Treated With Cisplatin-based Neoadjuvant Chemotherapy. Impact Journals LLC, 2014.